Pricing Log in Create free account

Alps Group Inc. (ALPS) vs Xilio Therapeutics, Inc. (XLO)

Alps Group Inc. and Xilio Therapeutics, Inc. are both Biotechnology companies. Alps Group Inc. and Xilio Therapeutics, Inc. are of similar size ($59.4M and $56.4M). Alps Group Inc. has the higher net margin (0.00% vs −34.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Alps Group Inc. leads on 6 and Xilio Therapeutics, Inc. on 4.

Valuation

Metric ALPS XLO Biotechnology median
P/E n/m n/m 8.50
P/S n/m 2.66 9.71
P/B n/m 2.36 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 0.56 9.21
Earnings yield (222.97%) (17.00%) (33.15%)
Free cash flow yield (82.17%) (36.00%) (25.50%)

Profitability

Metric ALPS XLO Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (48.94%) 0.00%
Net margin 0.00% (34.06%) 0.00%
Free cash flow margin 0.00% (95.59%) 0.00%
Return on equity 25.50% (55.03%) (56.36%)
Return on assets 0.00% (15.16%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALPS XLO Biotechnology median
Revenue growth (TTM) — 327.25% 6.02%
EPS growth (last fiscal year) 21.95% 72.55% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALPS XLO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.04 4.25 4.72
Net debt to EBITDA 0.00 3.40 0.96

Dividend

Metric ALPS XLO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ALPS XLO Biotechnology median
Market cap 56.41m 59.35m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack